NewsMakers9 years ago
FDA approves two hepatitis C drugs for pediatric patients
The U.S. Food and Drug Administration approved supplemental applications for Sovaldi (sofosbuvir) and Harvoni (ledipasvir and sofosbuvir) to treat hepatitis C virus (HCV) in children ages...
